Position in ANRO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,322,233
New position
Shares Held
429,035
first reported quarter
Ownership
1.09%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#22
of 114 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. ANRO ranks #19 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MBX |
MBX Biosciences, Inc.
|
800,173 | $44,169,549 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
435,691 | $35,539,314 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
919,266 | $28,340,970 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
485,661 | $26,065,425 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,377,576 | $25,306,071 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
669,046 | $24,828,297 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
|
256,950 | $24,346,012 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
397,379 | $23,985,796 |
All Filings in ANRO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,322,233 | 429,035 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||